Reeling under the US and UK import bans due to manufacturing quality lapses, drugmaker Wockhardt Ltd on Monday reported a 78% slump in March-quarter profit. The company's January-March net profit fell to Rs. 74.45 crore ($12.76 million) compared with Rs. 335 crore a year earlier. Its sales fell 30% to Rs. 1040 crore in the quarter.